How COVID-19 has affected Medtronic, Stryker, Johnson & Johnson’s shares over the last month

Despite bans on elective orthopedic procedures, large device companies have successfully pivoted to weather the COVID-19 pandemic.

Advertisement

Here’s how Medtronic, Stryker and Johnson & Johnson shares have fluctuated over the last month.

Note: Becker’s is using final numbers at market close for each day unless otherwise noted.

Medtronic:
April 1: $84.11
April 6: $94.06
April 13: $99.52
April 20: $101.54
April 27: $100.76
Percent change: 19.8 percent

Stryker:
April 1: $144.67
April 6: $165.66
April 13: $172.08
April 20: $184.72
April 27: $191.96
Percent change: 32.69 percent

Johnson & Johnson (DePuy Synthes)
April 1: $128.81
April 6: $139.76
April 13: $139.77
April 20: $151.67
April 27: $154.29
Percent change: 19.78 percent

More articles on surgery centers:
Life after ramp-up: How COVID-19 will change ASCs forever
3 ASC nurses join COVID-19 front lines in New York
4 hospitals, health systems opening ASCs

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.